Abbott Laboratories (Pakistan) (KAR:ABOT) ROCE % : 35.99% (As of Mar. 2024)

View and export this data going back to 1982. Start your Free Trial

What is Abbott Laboratories (Pakistan) ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Abbott Laboratories (Pakistan)'s annualized ROCE % for the quarter that ended in Mar. 2024 was 35.99%.

Abbott Laboratories (Pakistan) ROCE % Historical Data

The historical data trend for Abbott Laboratories (Pakistan)'s ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories (Pakistan) ROCE % Chart

Abbott Laboratories (Pakistan) Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

17.84

38.21

45.52

32.12

13.34

Abbott Laboratories (Pakistan) Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															5.36	8.47	7.19	33.45	35.99

Abbott Laboratories (Pakistan) ROCE % Calculation

Abbott Laboratories (Pakistan)'s annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	2611.897	/	( ( (33919.795 - 14607.276)	+	(36693.445 - 16835.213) )	/ 2 )
	=	2611.897	/	( (19312.519	+	19858.232)	/ 2 )
	=	2611.897	/	19585.3755
	=	13.34 %

Abbott Laboratories (Pakistan)'s ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	7451.064	/	( ( (36693.445 - 16835.213)	+	(36108.882 - 14560.631) )	/ 2 )
	=	7451.064	/	( ( 19858.232	+	21548.251 )	/ 2 )
	=	7451.064	/	20703.2415
	=	35.99 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Abbott Laboratories (Pakistan) (KAR:ABOT) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Abbott Laboratories (Pakistan) ROCE % Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories (Pakistan)'s ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbott Laboratories (Pakistan) (KAR:ABOT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott Laboratories (Pakistan) Ltd (KAR:ABOT) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Hyderabad Road, Landhi, P.O. Box 7229, Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Karachi, PAK, 75120

Website

https://www.pk.abbott

Abbott Laboratories (Pakistan) Ltd is engaged in manufacturing, importing, and marketing research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and also has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. Its Brands include Duphaston, Surbex Z, Serc, Duphala, Pediasur, Similac, and others.

Abbott Laboratories (Pakistan) (KAR:ABOT) Headlines

No Headlines